http://www.triadisotopes.com/ 1.00 monthly http://www.triadisotopes.com/index.shtml 0.80 monthly http://www.triadisotopes.com/ICL/index.shtml 0.80 monthly http://www.triadisotopes.com/company/index.shtml 0.80 monthly http://www.triadisotopes.com/difference/index.shtml 0.80 monthly http://www.triadisotopes.com/products/index.shtml 0.80 monthly http://www.triadisotopes.com/service/index.shtml 0.80 monthly http://www.triadisotopes.com/news/index.shtml 0.80 monthly http://www.triadisotopes.com/partner/index.shtml 0.80 monthly http://www.triadisotopes.com/contact/sales-mktg-team.shtml 0.80 monthly http://www.triadisotopes.com/location/index.shtml 0.80 monthly http://www.triadisotopes.com/accreditation/index.shtml 0.80 monthly http://www.triadisotopes.com/reimbursement/index.shtml 0.80 monthly http://www.triadisotopes.com/contact/index.shtml 0.80 monthly http://www.triadisotopes.com/press-release/index.shtml 0.80 monthly http://www.triadisotopes.com/ICL/pdf/nopr-cms-expand.pdf 0.64 monthly http://www.triadisotopes.com/ICL/pdf/king-pharmaceuticals.pdf 0.64 monthly http://www.triadisotopes.com/press-release/03-12-2008.shtml 0.64 monthly http://www.triadisotopes.com/press-release/institute-clinical.shtml 0.64 monthly http://www.triadisotopes.com/ICL/pdf/NOPR releases preliminary results of PET treatment strategies_V2.pdf 0.64 monthly http://www.triadisotopes.com/ICL/pdf/icl-cib-final-final.pdf 0.64 monthly http://www.triadisotopes.com/ICL/pdf/icl-cib-mar08_Layout 3-03-08.pdf 0.64 monthly http://www.triadisotopes.com/ICL/pdf/icl-whitepaper1_ 12-12-07.pdf 0.64 monthly http://www.triadisotopes.com/press-release/diabetes-flyer.pdf 0.64 monthly http://www.triadisotopes.com/ICL/continuing-educ/index.shtml 0.64 monthly http://www.triadisotopes.com/company/pdf/code-of-conduct.pdf 0.64 monthly http://www.triadisotopes.com/company/pdf/notice-of-privacy-practices-9-23-08.pdf 0.64 monthly http://www.triadisotopes.com/products/pet.shtml 0.64 monthly http://www.triadisotopes.com/products/nuclear-medicine.shtml 0.64 monthly http://www.triadisotopes.com/products/nuclear-cardiology.shtml 0.64 monthly http://www.triadisotopes.com/products/nuclear-oncology.shtml 0.64 monthly http://www.triadisotopes.com/products/brachytherapy.shtml 0.64 monthly http://www.triadisotopes.com/press-release/birmingham-acquisition.shtml 0.64 monthly http://www.triadisotopes.com/press-release/11-08-2007.shtml 0.64 monthly http://www.triadisotopes.com/news/pdf/mds-dom-letter.pdf 0.64 monthly http://www.triadisotopes.com/news/pdf/nordion-customer-letter-23-may-08.pdf 0.64 monthly http://www.triadisotopes.com/contact/pharmacy.shtml 0.64 monthly http://www.triadisotopes.com/accreditation/gold-level.shtml 0.64 monthly http://www.triadisotopes.com/accreditation/platinum-level.shtml 0.64 monthly http://www.triadisotopes.com/reimbursement/snm-rates.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/new-revised-hcpcs-codes.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/AuntMinnie.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/UnitedFAQ.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/Reimbursement-Update-1-08-08.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/UHC_Accreditation_Extension_Letter[1].pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/UHC Accred_FAQs_final pdf_Jan_20081.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/cms-doc.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/01cardiac.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/02neuro.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/03oncology.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/Reimbursement-DAMPQRI.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/Reimbursement-flash.pdf 0.64 monthly http://www.triadisotopes.com/reimbursement/DOC110807.pdf 0.64 monthly http://www.triadisotopes.com/thallium/Thallium ReimbursementRates 12-06-07.pdf 0.64 monthly http://www.triadisotopes.com/thallium/pdf/Myocardial Perfusion Coding Sheet Thallium.doc 0.64 monthly http://www.triadisotopes.com/press-release/04-24-2008.shtml 0.64 monthly